Compare Medpace Holdings Inc (MEDP) vs Atlassian Corporation PLC (TEAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Atlassian Corporation PLC — how do they compare? Medpace Holdings Inc trades at $597.39 (market cap $16.90B), while Atlassian Corporation PLC trades at $154.17 (market cap $39.10B). The key difference: Atlassian Corporation PLC is far larger — about 2.3× Medpace Holdings Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Atlassian Corporation PLC nearer its low. Which is the better fit depends on your goals.
| MEDP | TEAM | |
|---|---|---|
Market Cap | $16.90B | $39.10B |
Sector | Technology | Technology |
52-Week High | $620.59 | $182.36 |
52-Week Low | $393.42 | $57.15 |
Enterprise Value | $16.52B | $39.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $596.98, down 0.9% on the day but near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and recent golden cross formation. Fundamentally, the company delivered three consecutive quarterly earnings beats with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue growth remains robust at 17.2% year-over-year in Q2 2026, supported by record net bookings and a $3.0 billion backlog.
MEDP presents a growth story with strong fundamentals but trades at premium valuations (P/E 35.58, P/S 6.27). The primary investment opportunity lies in continued execution on record bookings and backlog conversion. Key risks include the ongoing shareholder litigation investigation and potential valuation compression if growth moderates. Analyst consensus targets $599.57 with 21% buy ratings, suggesting limited near-term upside from current levels.
Atlassian (TEAM) trades at $155.15, up 2.16% with strong momentum following a 35% surge post-earnings. The stock shows bullish technical signals with moving averages supporting upward trends, though RSI indicates overbought conditions. Fundamentally, revenue growth remains robust at 28% YoY in Q4 2026, with cloud revenue accelerating to 31% and the company achieving its first full year of GAAP profitability. Analyst sentiment is overwhelmingly positive with 67% buy ratings and a $161.93 consensus target.
Outlook remains favorable with AI platform adoption and enterprise deal expansion driving growth, though valuation metrics appear stretched with EV/EBITDA at 184x. Key risks include competitive pressures in software and execution challenges in maintaining cloud momentum. The stock's proximity to 52-week highs suggests potential for consolidation near current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Atlassian Corporation PLC
Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →
